Beynleumi Hanpakot: How NIS 2.44 Billion of Commercial Paper Changes the 2026 Read
The main article showed that 2025 expanded the balance sheet without building a real capital cushion. This continuation isolates what that means in practice: NIS 2.442 billion of commercial paper became the largest liability bucket and the core 2026 rollover issue, while only NIS 0.51 million of cash remained at year-end.
The main article made the broad point: Beynleumi Hanpakot ended 2025 with a much larger balance sheet and with an equity cushion that barely moved. This continuation does not revisit the whole structure. It isolates the layer that actually changes the 2026 read, commercial paper, which moved from zero at the end of 2024 to NIS 2.442 billion at the end of 2025.
That deserves its own read because commercial paper changes the type of risk. With longer bonds, the question is mainly duration and cost. With commercial paper, the question is first and foremost rollover. It is also not an incidental layer anymore. By year-end 2025 it had already become the largest liability bucket. So anyone trying to understand 2026 should spend less time on a few hundred thousand shekels of annual profit and more time on the actual maturity wall, what really backs it, and what the new shelf prospectus does and does not solve.
The 2026 Maturity Wall
The first number is NIS 2.442 billion, the carrying value of the two commercial-paper series at the end of 2025. But even that understates the cash test. In the liquidity-risk note, the contractual cash flow attached to commercial paper reaches NIS 2.523 billion, and all of it sits in the 6 to 12 month bucket. In other words, the 2026 read is not just about a balance-sheet line. It is about more than NIS 2.5 billion of cash obligations inside one year.
The second number matters just as much. Out of NIS 2.881 billion of total contractual liability cash flow falling within 12 months, about 87.6% comes from commercial paper. This is no longer one funding layer among many. It is the layer that explains almost the entire near-term rollover test.
The third number is the smallest and may be the most important. Beynleumi Hanpakot ended 2025 with only NIS 510 thousand of cash and cash equivalents, up from NIS 290 thousand a year earlier. That is the key reminder. On an all-in cash-flexibility view, the issuer did not build an independent liquidity reserve for 2026. The money moved through the company and was deposited with First International Bank. Anyone looking for a real standalone cash buffer at the issuer level will simply not find one.
The chart makes the shift obvious. At the end of 2024, the near-term maturity wall was almost entirely bonds. At the end of 2025, it became overwhelmingly commercial paper. That is why 2026 is not just another funding year. It is a test year for a very large short-dated funding layer that appeared quickly and all at once.
The Structure Matches, But It Does Not Create A Cushion
It is easy to misread the new commercial-paper layer as a market-risk or spread-risk story. That is only partly true. Structurally, the company keeps a very tight symmetry: the proceeds of the issues were deposited with First International Bank on terms identical to those of the commercial paper, and that pattern appears on both the asset side and the liability side of the notes.
| Series | Issue date | Maturity date | CP carrying value at end-2025 | Matching short-term deposit at end-2025 | Annual rate at end-2025 | Pricing mechanism |
|---|---|---|---|---|---|---|
| CP 1 | September 4, 2025 | September 4, 2026 | NIS 1.318803 billion | NIS 1.318407 billion | 4.51% | Weighted average Bank of Israel rate plus 0.01% |
| CP 2 | November 26, 2025 | November 26, 2026 | NIS 1.123406 billion | NIS 1.123069 billion | 4.54% | Weighted average Bank of Israel rate plus 0.04% |
The small year-end gaps between the deposits and the liabilities do not change the core point. The core point is that the company is taking very little basis risk between the asset and the liability. The commercial-paper rate and the deposit rate are both anchored to the same reference, Bank of Israel rate, with very small fixed margins. That means 2026 is not primarily a story about margin compression inside the issuer. It is a story about market access and the ability to renew the paper on time.
This is also exactly where the structure helps on one axis and concentrates risk on another. On the supportive side, First International Bank undertook to bear all payments to holders of the commercial paper, bonds, and subordinated notes, and the company also benefits from an indemnity letter and from the bank bearing issuance and ongoing operating costs. On the other side, the liquidity-risk note says this explicitly: the company's ability to repay its obligations depends on the repayment of the deposits and deferred deposits by First International Bank.
Put more directly, without softening it: the structure solves most of the mismatch risk between assets and liabilities. It does not solve concentration. The entire chain, both the asset side and the liquidity side, still sits on one sponsor bank.
What The New Shelf Prospectus Solves, And What It Does Not
After the balance-sheet date, on February 25, 2026, the company published a new shelf prospectus dated February 26, 2026. That matters. Without it, the company would not have had an updated issuance platform after the older shelf prospectus had only been extended through February 1, 2026. In that sense, the new shelf prospectus does solve a real problem: it restores the legal ability to issue again.
But this is where the distinction matters. A shelf prospectus is not liquidity. It is also not an automatic term extension, and it does not erase maturities that have already been fixed. The two commercial-paper series issued in 2025 mature in one bullet payment, in September and November 2026. The company is also not allowed to redeem the commercial paper early on its own initiative. So the new shelf prospectus does not remove the maturity wall. It only opens the door to attempt a rollover.
The 2025 cash-flow statement is the cleanest proof of that distinction. During the year the company raised NIS 2.419 billion of commercial paper and NIS 1.7 billion of bonds, but in the same year it placed NIS 2.450 billion into short-term deposits with the bank and another NIS 1.704 billion into long-term deposits. After all of that activity, cash at the issuer level increased by only NIS 220 thousand.
That is the core separation between what the new shelf solves and what it does not:
- It does preserve room to act.
- It does not create independent issuer liquidity.
- It does not extend Series 1 and 2, which still mature in 2026.
- It does not eliminate dependence on actual investor demand for the next round.
That also explains the right way to read pricing. Because both commercial-paper series carry interest based on Bank of Israel rate plus 0.01% and 0.04%, the 2026 question is not whether the company has found a new earnings engine. It has not. The question is whether the market remains willing to fund a short-dated issuance vehicle like this, and at what price.
What Needs To Be Seen In 2026
Once the mechanical matching is separated from rollover risk, the 2026 checkpoints become much sharper.
Checkpoint one: whether the company starts renewing the commercial-paper layer early enough ahead of the September and November 2026 maturities. A new shelf prospectus gives it the option. It does not guarantee execution.
Checkpoint two: the price of that rollover. Because the back-to-back structure sharply limits basis risk, any meaningful change in required pricing or demand would mostly reflect the market's reading of liquidity access and sponsor dependence, not an internal operating problem.
Checkpoint three: whether the market continues to view Beynleumi Hanpakot as a near-direct extension of First International Bank, or starts asking for a distinct premium on the issuer shell itself. As long as the first view holds, NIS 2.44 billion of commercial paper looks like an efficient short-funding tool. If the second view starts to emerge, this becomes the first pressure point in the structure.
Checkpoint four: whether the company simply recreates the short wall one year forward or uses 2026 to push part of the funding mix back toward longer duration. The 2025 report showed a sharp move toward short funding. 2026 will show whether that was a one-off opening of a new channel or a deeper change in the funding profile.
The bottom line of this continuation is simpler than the headline. 2025 did not make Beynleumi Hanpakot more fragile because of an asset-liability mismatch. It made the company more sensitive to the market calendar. That is a meaningful difference. With NIS 2.442 billion of commercial paper on the balance sheet and NIS 2.523 billion of contractual cash needs within one year, 2026 will be judged by the company's ability to roll, not by its ability to explain.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.